Skip to main content
$166.88 +3.56 (+2.18%)
Market Cap
$6.18B
Shares
37.82M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$163.32 Open$169.50 Day$161.17–176.38 52W$98.27–176.38 Avg vol 30d546K Short int5.3M · 14.0% float · 9.3d Short vol51% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.2 · calm Equity put/call 0.60
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +22%
      above
      Price vs 50-day avg +6%
      above
      RSI (14) 62
      neutral
      MACD trend Positive
      52-week position 83%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +8%
      trailing
      6-month return +17%
      trailing
      YTD return +37%
      this year
      Relative strength +4%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $154 › 200d $134 — 50d above 200d
      Institutional flow Accumulating
      158 of 335 funds reported for Jun 30 · net +1.8M sh shares · +39 new
      Insider flow Distributing
      Net -$2.2M over 90 days · 100% sells
      Short interest Rising
      13.99% of float · ▲ +0.7% MoM · 9.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      335 holders — near 3-yr high, broad support
      Squeeze score 99
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +35%
      Y/Y
      Gross margin 84%
      contracting
      EPS growth −17%
      Y/Y
      Free cash flow $48.4M
      Valuation P/E 104
      rich
      Buyback $191.6M
      remaining
      Balance sheet $130.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 52%
      annualized · 1-yr
      Max drawdown −27%
      past year
      ATR 5.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 5, 2026
      third quarter of 2026
      GAAP revenue Initiated $300M – $304M
      prior qtr $265.81M midpoint +13.6% QoQ
      Adjusted Diluted EPS Initiated $0.95 – $1.00
      Adjusted EBITDA Initiated $74M – $77M
      full year 2026
      GAAP revenue Raised $1.13B – $1.14B
      prior FY $980.6M midpoint +15.7% Y/Y
      Adjusted EBITDA Raised $273M – $278M
      Adjusted Diluted EPS Raised $3.68 – $3.74
      Guided vs delivered · last 1 settled
      GAAP revenue second quarter of 2026
      guided $259M – $264M
      $265.81M Beat +1.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +22% Bullish
      Price vs 50-day avg
      +6% Bullish
      RSI (14)
      62 Neutral
      MACD trend
      Positive Bullish
      52-week position
      83% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $154 › 200d $134 — 50d above 200d
      Institutional flow Accumulating
      158 of 335 funds reported for Jun 30 · net +1.8M sh shares · +39 new
      Insider flow Distributing
      Net -$2.2M over 90 days · 100% sells
      Short interest Rising
      13.99% of float · ▲ +0.7% MoM · 9.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      335 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $98 Now $163 · 83% 52-wk high $176
      vs 200-day avg +22% vs 50-day avg +6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted Gross Profit Margin non-GAAP 47.1% Three Months Ended July 3, 2026
      Book-to-bill 1.11 the fourth quarter
      Net Debt non-GAAP -$121M Year Ended December 31, 2025

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Scientific & Technical Instruments — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NOVT
      Novanta Inc
      this stock
      $6.18B +37.3% +35.5% 104.0 14.0%
      COHR
      Coherent Corp.
      $65.39B +81.1% +19.2% 158.4 4.4%
      GRMN
      Garmin Ltd
      $58.22B +50.0% +15.1% 33.7 2.0%
      KEYS
      Keysight Technologies, Inc.
      $57.58B +65.8% +8.0% 55.2 1.8%
      TDY
      Teledyne Technologies Inc
      $31.87B +34.6% +24.1% 33.3 2.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      367
      % held
      106.7%
      Reported
      158 of 335
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      410
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      5.3M
      Days to cover
      9.3d
      Change
      +34.7K sh
      View
      Short Volume
      Short vol %
      51%
      As of
      Aug 6, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      192.9K
      Value
      $28.9M
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      40.5%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$2.2M
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      May 18, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $980.6M
      Net income (FY)
      $53.8M
      EPS diluted
      $1.47
      View
      Buybacks
      Authorized
      $200.0M
      Remaining
      $191.6M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 5, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $845.0K
      Shares
      6.5K
      Filed
      Mar 2, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      Novanta Completes Acquisition of…
      Published
      Jul 27, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NOVT +17.6% +7.7% +17.3% +14.6% +37.3%
      SPY +3.6% +2.2% +12.8% +2.9% +12.7%
      vs SPY +14.0% +5.5% +4.4% +11.7% +24.6%

      Capital returns

      Buyback program · as of Jul 3, 2026
      Authorized
      $200.00M
      Spent (derived)
      $8.40M
      Remaining
      $191.60M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1076930 CUSIP 67000B104 13F (30d) 146 filings 142 filers Visit website Investor relations